Perampanel 0.5 mg in 1 mL Oral Suspension
RxNorm 1790122
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1790122 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: perampanel 0.5 mg in 1 mL Oral Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Perampanel 0.5 mg/ML Oral Suspension
(Atom ID: 8213040)
PSNPrescribable
Prescribable Name (PSN):
Perampanel 0.5 mg in 1 mL Oral Suspension
(Atom ID: 8213053)
SYPrescribable
Synonym (SY):
Perampanel 0.5 mg per 1 mL Oral Suspension
(Atom ID: 8213050)
PTPrescribable
Designated preferred name (PT):
Perampanel 500 microgram/mL oral suspension
(Atom ID: 12791466)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely perampanel 500 microgram/1 mL conventional release oral suspension (clinical drug)
(Atom ID: 12791600)
Patient Education
Perampanel
Perampanel is used to treat certain types of partial onset seizures (seizures that involve only one part of the brain) in adults and children 4 years of age and older. It is also used in combination with other medications to treat certain types of primary generalized tonic-clonic seizures (formerly known as a grand mal seizure; seizure that involves the entire body) in adults and children 12 years of age or older. Perampanel is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.